Simon, B.; Rubey, H.; Gromann, M.; Knopf-Völkerer, A.; Hemedi, B.; Zehetmayer, S.; Kirsch, B.
SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls. Vaccines 2022, 10, 694.
https://doi.org/10.3390/vaccines10050694
AMA Style
Simon B, Rubey H, Gromann M, Knopf-Völkerer A, Hemedi B, Zehetmayer S, Kirsch B.
SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls. Vaccines. 2022; 10(5):694.
https://doi.org/10.3390/vaccines10050694
Chicago/Turabian Style
Simon, Benedikt, Harald Rubey, Martin Gromann, Astrid Knopf-Völkerer, Boris Hemedi, Sonja Zehetmayer, and Bernhard Kirsch.
2022. "SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls" Vaccines 10, no. 5: 694.
https://doi.org/10.3390/vaccines10050694
APA Style
Simon, B., Rubey, H., Gromann, M., Knopf-Völkerer, A., Hemedi, B., Zehetmayer, S., & Kirsch, B.
(2022). SARS-CoV-2 Antibody and T Cell Response after a Third Vaccine Dose in Hemodialysis Patients Compared with Healthy Controls. Vaccines, 10(5), 694.
https://doi.org/10.3390/vaccines10050694